VERTEX PHARMACEUTICALS INCORPORATED Funds and ETFs Vertex Pharmaceuticals Incorporated
Equities
VRTX
US92532F1003
Biotechnology & Medical Research
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 398.6 USD | +0.24% |
|
+1.15% | -1.98% |
ETFs positioned on Vertex Pharmaceuticals Incorporated
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 7.67% | 0 M€ | 0.00% | - | |
| 7.08% | 0 M€ | 0.00% | - | |
| 5.20% | 2 M€ | -.--% | ||
| 4.81% | 7 M€ | -.--% | - | |
| 4.05% | 115 M€ | +5.67% | - | |
| 3.53% | 1 M€ | 0.00% | - | |
| 2.32% | 2 M€ | +6.77% | ||
| 2.28% | 8 M€ | +2.44% | ||
| 1.99% | 12 M€ | +15.09% | - | |
| 1.93% | 1 M€ | 0.00% | - | |
| 1.71% | 2 M€ | -25.75% | ||
| 1.63% | 18 M€ | +3.79% | - | |
| 1.61% | 267 M€ | +5.97% | ||
| 1.58% | 9 M€ | -4.31% | - | |
| 1.10% | 204 M€ | +10.54% | ||
| 1.06% | 1,182 M€ | +1.10% | ||
| 0.87% | 9 M€ | -.--% | - | |
| 0.82% | 13 M€ | -.--% | - | |
| 0.82% | 3 M€ | +15.16% | - | |
| 0.82% | 4 M€ | -.--% | - | |
| 0.81% | 26 M€ | +16.85% | - | |
| 0.73% | 22 M€ | 0.00% | - | |
| 0.69% | 5 M€ | -72.95% | - | |
| 0.68% | 3 M€ | 0.00% | - | |
| 0.51% | 717 M€ | +6.20% |
Vertex Pharmaceuticals Incorporated specializes in the research, development and marketing of micromolecular drugs primarily for the treatment of cancers, viral, inflammatory and auto-immune diseases.
Net sales are distributed geographically as follows: the United States (61.2%), Europe (31.5%) and other (7.3%).
Calendar
2024-05-06
- Q1 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
33
Last Close Price
397.7
USD
Average target price
459.7
USD
Spread / Average Target
+15.60%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -1.98% | 103B | |
| +0.19% | 95.71B | |
| +1.69% | 22.02B | |
| -17.03% | 20.9B | |
| -9.30% | 17.85B | |
| -41.01% | 16.21B | |
| -14.82% | 15.52B | |
| +3.66% | 13.86B | |
| +34.69% | 12.04B | |
| -25.48% | 8.08B |
- Stock Market
- Equities
- VRTX Stock
- Funds and ETFs Vertex Pharmaceuticals Incorporated
